Investor Sues Drugmaker Over Lack Of Control Group In Trials
An investor in drugmaker Tyme Technologies Inc. filed suit against the biotechnology company in New York federal court on Monday, claiming its failure to include a control group in clinical trials...To view the full article, register now.
Already a subscriber? Click here to view full article